Literature DB >> 15919916

Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative epstein-barr virus.

R Feederle1, C Shannon-Lowe, G Baldwin, H J Delecluse.   

Abstract

The Epstein-Barr virus (EBV) lytic program includes lytic viral DNA replication and the production of a viral particle into which the replicated viral DNA is packaged. The terminal repeats (TRs) located at the end of the linear viral DNA have been identified as the packaging signals. A TR-negative (TR(-)) mutant therefore provides an appropriate tool to analyze the relationships between EBV DNA packaging and virus production. Here, we show that supernatants from lytically induced 293 cells carrying TR mutant EBV genomes (293/TR(-)) contain large amounts of viral particles devoid of viral DNA which are nevertheless able to bind to EBV target cells. This shows that viral DNA packaging is not a prerequisite for virion formation and egress. Rather surprisingly, supernatants from lytically induced 293/TR(-) cells also contained rare infectious viruses carrying the viral mutant DNA. This observation indicates that the TRs are important but not absolutely essential for virus encapsidation.

Entities:  

Mesh:

Year:  2005        PMID: 15919916      PMCID: PMC1143645          DOI: 10.1128/JVI.79.12.7641-7647.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.

Authors:  J Menezes; W Leibold; G Klein; G Clements
Journal:  Biomedicine       Date:  1975-07

3.  Relationship of herpes simplex virus genome configuration to productive and persistent infections.

Authors:  Sara A Jackson; Neal A DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

4.  Herpes simplex virus amplicon: cleavage of concatemeric DNA is linked to packaging and involves amplification of the terminally reiterated a sequence.

Authors:  L P Deiss; N Frenkel
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

6.  The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure.

Authors:  Hanno Scheffczik; Christos G W Savva; Andreas Holzenburg; Larissa Kolesnikova; Elke Bogner
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

7.  Sequence complexity of circular Epstein-Bar virus DNA in transformed cells.

Authors:  B E Griffin; E Björck; G Bjursell; T Lindahl
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

8.  Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.

Authors:  T Gardella; P Medveczky; T Sairenji; C Mulder
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

Review 10.  Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?

Authors:  A Mandic; T Vujkov
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

View more
  19 in total

1.  EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

Authors:  Nara Lee; Walter N Moss; Therese A Yario; Joan A Steitz
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

2.  The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication.

Authors:  R Feederle; H Bannert; H Lips; N Müller-Lantzsch; H-J Delecluse
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

3.  An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA.

Authors:  Sophia Pavlova; Regina Feederle; Kathrin Gärtner; Walter Fuchs; Harald Granzow; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

4.  RNAs in Epstein-Barr virions control early steps of infection.

Authors:  Simon Jochum; Romana Ruiss; Andreas Moosmann; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-27       Impact factor: 11.205

5.  A virus-like particle-based Epstein-Barr virus vaccine.

Authors:  Romana Ruiss; Simon Jochum; Gerhard Wanner; Gilbert Reisbach; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

6.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Authors:  Stefanie Iskra; Markus Kalla; Henri-Jacques Delecluse; Wolfgang Hammerschmidt; Andreas Moosmann
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  EBV noncoding RNA EBER2 interacts with host RNA-binding proteins to regulate viral gene expression.

Authors:  Nara Lee; Therese A Yario; Jessica S Gao; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

9.  Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles.

Authors:  Marisa Granato; Regina Feederle; Antonella Farina; Roberta Gonnella; Roberta Santarelli; Birgit Hub; Alberto Faggioni; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

10.  Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles.

Authors:  Dinesh Adhikary; Uta Behrends; Regina Feederle; Henri-Jacques Delecluse; Josef Mautner
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.